
- Pharmaceutical Technology-08-02-2006
- Volume 30
- Issue 8
FDA Boosts User Fees 17-19% for FY 2007
The US Food and Drug Administration announced its Prescription Drug User Fee Amendments of 2002 (PDUFA II) fees schedule for fiscal year 2007 (Oct. 1, 2006 - Sept. 30, 2007), including increases ranging from 17% to 19%.
In an Aug. 2
- $896,200 for an application requiring clinical data, up 17% from $767,400 for FY 2006;
- $448,100 for an application not requiring clinical data or a supplement requiring clinical data, up 17% from $383,700;
- $313,100 for establishment fees, up 19% from $264,000;
- $49,750 for product fees, up 18% from $42,130.
The agency will begin issuing invoices for establishment and product fees under the new schedule this month.
Reference
1. US Food and Drug Administration, "Prescription Drug User Fee Rates for Fiscal Year 2007," Federal Register 71 (148), 43780–43784 (Aug. 2, 2006). DOCID:fr02au06-96.
Articles in this issue
over 20 years ago
Schering Recalls Ultravist Injectionover 20 years ago
The Modern Soapboxover 20 years ago
Reinventing FDA: A Mid-Course Reportover 20 years ago
Cracking Down on Counterfeitingover 20 years ago
Our Readers Write Inover 20 years ago
Rolling Out Advances in Chiral Chemistryover 20 years ago
China Just Around the Cornerover 20 years ago
August 2006over 20 years ago
Is "Satisfactory" Contractor Performance Good Enough?over 20 years ago
FDA Marks 100 Years of Drug Manufacturing OversightRelated to this article








